Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionOral interleukin-2 inducible T cell kinase inhibitor
Molecular Target Inducible T cell kinase (ITK)
Mechanism of ActionInterleukin-2 (IL-2) receptor agonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today